- Home
- Publications
- Publication Search
- Publication Details
Title
Treating p53 Mutant Aggregation-Associated Cancer
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 6, Pages 154
Publisher
MDPI AG
Online
2018-05-23
DOI
10.3390/cancers10060154
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Monoclonal Antibodies against Specific p53 Hotspot Mutants as Potential Tools for Precision Medicine
- (2018) Le-Ann Hwang et al. Cell Reports
- Mutant p53 as a target for cancer treatment
- (2017) Michael J. Duffy et al. EUROPEAN JOURNAL OF CANCER
- Nuclear inclusion bodies of mutant and wild-type p53 in cancer: a hallmark of p53 inactivation and proteostasis remodelling by p53 aggregation
- (2017) Frederik De Smet et al. JOURNAL OF PATHOLOGY
- Inhibition of p53 Mutant Peptide Aggregation In Vitro by Cationic Osmolyte Acetylcholine Chloride
- (2017) Mathumai Kanapathipillai et al. PROTEIN AND PEPTIDE LETTERS
- p21: A Two-Faced Genome Guardian
- (2017) Alexandros G. Georgakilas et al. TRENDS IN MOLECULAR MEDICINE
- Dynamics of p53: A Master Decider of Cell Fate
- (2017) Qingyin Luo et al. Genes
- A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas
- (2016) Alice Soragni et al. CANCER CELL
- Amyloidogenicity of p53: A Hidden Link Between Protein Misfolding and Cancer
- (2015) Hao Gong et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Role of acetylcholinesterase in lung cancer
- (2015) Hui-Jun Xi et al. Thoracic Cancer
- Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment
- (2014) Mathumai Kanapathipillai et al. ADVANCED DRUG DELIVERY REVIEWS
- The threads that tie protein-folding diseases
- (2014) J. L. Brodsky Disease Models & Mechanisms
- Mechanisms of protein-folding diseases at a glance
- (2014) J. S. Valastyan et al. Disease Models & Mechanisms
- The aggregation of mutant p53 produces prion-like properties in cancer
- (2014) Luciana P Rangel et al. Prion
- Targeting p53 for Novel Anticancer Therapy
- (2014) Zhen Wang et al. Translational Oncology
- Prion-like aggregation of mutant p53 in cancer
- (2014) Jerson L. Silva et al. TRENDS IN BIOCHEMICAL SCIENCES
- p53 Aggregates Penetrate Cells and Induce the Co-Aggregation of Intracellular p53
- (2013) Karolyn J. Forget et al. PLoS One
- Dual role of p53 amyloid formation in cancer; loss of function and gain of toxicity
- (2012) Cristian A. Lasagna-Reeves et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The rebel angel: mutant p53 as the driving oncogene in breast cancer
- (2012) D. Walerych et al. CARCINOGENESIS
- Mutant p53: one name, many proteins
- (2012) W. A. Freed-Pastor et al. GENES & DEVELOPMENT
- Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils
- (2012) Ana P. D. Ano Bom et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gain of function of mutant p53 by coaggregation with multiple tumor suppressors
- (2011) Jie Xu et al. Nature Chemical Biology
- Inhibition of β-amyloid peptide aggregation and neurotoxicity by α-d-mannosylglycerate, a natural extremolyte
- (2008) Jungki Ryu et al. PEPTIDES
- Small stress molecules inhibit aggregation and neurotoxicity of prion peptide 106–126
- (2007) Mathumai Kanapathipillai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started